December 11, 2007
Article
The Gynecologic Cancer Foundation releases its 2007 annual report.
Optune Plus Temodar and Keytruda May Result in Brain Tumor Control
ICI Response May Predict Relapse-Free Survival in Liver Cancer
Taking Time to ‘Smell the Roses’
Addressing Pros and Cons of CAR-T Cell Therapy in Melanoma